abstract |
FIELD: medicinal sealing materials. SUBSTANCE: fibrin sealer, in particular, thrombin-free composition containing fibrin monomer or composition containing non-cross-linking fibrin is applied by bringing it into contact with required area. In this procedure, fibrin monomer converts into fibrin polymer thereby manifesting sealing effect. Thrombin-free aqueous composition containing non-cross-linking fibrin is used in concentration 10 to 200 mg/ml. EFFECT: avoided risk of viral infection or other adverse effects. 70 cl, 1 dwg, 2 tbl |